Resultados de la búsqueda 31-40 of 12147 for Obesity/Overweight Treatment
Our Patient Blood Management Program seeks to improve the blood health of patients receiving care at Mayo Clinic. This includes the use of evidence-based and ...
... obesity (BMI ≥ 40). Efineptakin alfa (NT-I7) Plus Pembrolizumab for the Treatment of Recurrent Glioblastoma. Rochester, Minn. The purpose of this study is ...
... management for early-stage endometrial cancer and complex atypical hyperplasia due to morbid obesity (BMI ≥ 40). Numeración de páginas Estudios clínicos.
Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. A ...
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 1 ... treatment, post-treatment and (when available) ... Investigating the Link ...
... management for early-stage endometrial cancer and complex atypical hyperplasia due to morbid obesity (BMI ≥ 40). T-DM1 and Tucatinib Compared With T-DM1 ...
Accessed Oct. 12, 2020. Prescription medications to treat overweight and obesity. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.
... treated with Continuous Kidney Replacement Therapy (CKRT). ... obesity. However, it is unclear how sleep apnea ... treatment and errors will be caught and corrected ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?